Blog

Impact of COVID-19 on medtech innovation investing

Impact of COVID-19 on medtech innovation investing 08 June, 2020 Bernard Vogel, Managing Partner at Endeavour Vision The medtech industry has never in history been of such pivotal importance as in the last few months during the pandemic. As countries all over the world grappled with the devastating [...]

2020-06-10T09:19:42+01:00June 8th, 2020|All News, Blog|

Gynesonics receives FDA clearance to market next generation Sonata® System 2.1

Gynesonics receives FDA clearance to market next generation Sonata® System 2.1 Early launch in Europe contributes to significant procedural growth Redwood City, CA – May 28, 2020 – Gynesonics, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, announced today that it [...]

2020-05-29T11:55:11+01:00May 29th, 2020|All News, Blog|

Rapid Micro Biosystems Raises $120 Million to Accelerate Global Expansion of Contaminant Testing Platform for Pharmaceutical and Vaccine Manufacturing

Rapid Micro Biosystems Raises $120 Million to Accelerate Global Expansion of Contaminant Testing Platform for Pharmaceutical and Vaccine Manufacturing Proceeds will enable the company to meet growing demand for its automated microbial detection platform, currently used by a majority of the top 20 global biopharmaceutical companies, and support [...]

2020-05-20T12:42:46+01:00May 20th, 2020|All News, Blog|

Molecular Partners Confirms Ultra-Potent Inhibition of SARS-CoV-2 Live Virus by Anti-COVID-19 DARPin® Candidates

Molecular Partners Confirms Ultra-Potent Inhibition of SARS-CoV-2 Live Virus by Anti-COVID-19 DARPin® Candidates DARPin® antiviral candidates demonstrate low picomolar potency in live virus assay Candidate construction complete; two candidates ready for preclinical development & manufacturing Therapeutic profile of a highly potent antiviral biologic with a long half-life supports [...]

2020-05-14T11:19:01+01:00May 14th, 2020|All News, Blog|

Endeavour Vision interview with AGEFI – Impact of COVID-19 on investments in starts-ups, the medtech sector and the firm’s investment strategy

Endeavour Vision's Co-Founder and Managing Partner, Bernard Vogel, spoke to the Swiss news publication, AGEFI, to share his insights on the impact of COVID-19 on Swiss start-ups, the med tech sector and the firm's investment strategy. Scroll down for the English translation. Published in AGEFI on 20 April, [...]

2020-04-27T17:57:13+01:00April 27th, 2020|All News, Blog|

Interview with Bradley Paddock, CEO of CeQur

Interview with Bradley Paddock, CEO of CeQur In June 2019, Bradley Paddock joined CeQur®, as Chief Executive Officer. We spoke to Bradley to hear about his first 6 months in the company and discuss the up-coming U.S. launch of its three-day insulin delivery device for type 2 diabetes.  [...]

2020-01-06T11:51:06+00:00January 6th, 2020|All News, Blog|

Endeavour Vision accelerates investments in Switzerland and the US – an interview with AGEFI

Endeavour Vision accelerates investments in Switzerland and the US – an interview with AGEFI Endeavour Vision Founding Partners Damien Tappy and Bernard Vogel spoke to AGEFI about the next fund and the firm’s investment approach. Read the article from AGEFI here Medtech: Endeavour Vision accélère ses investissements en [...]

2019-10-11T12:00:45+01:00September 9th, 2019|All News, Blog|

Interview with Rob Barmann, Senior Investment Director at Endeavour Vision

Interview with Rob Barmann, Senior Investment Director at Endeavour Vision Previously Vice President, Corporate Business Development at Boston Scientific. Rob, you joined Endeavour Vision after 15 years working at Boston Scientific, can you summarise your role there? My job was to assess and execute business development transactions including acquisitions, [...]

2019-10-10T09:41:58+01:00July 24th, 2019|All News, Blog|
Go to Top